298 related articles for article (PubMed ID: 11877569)
1. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
[TBL] [Abstract][Full Text] [Related]
2. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Eguchi A; Takei T; Yoshida T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study.
Clasen W; Kindler J; Mihatsch MJ; Sieberth HG
Nephrol Dial Transplant; 1988; 3(6):733-7. PubMed ID: 3147414
[TBL] [Abstract][Full Text] [Related]
6. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
8. Glomerular glucocorticoid receptor expression is reduced in late responders to steroids in adult-onset minimal change disease.
Han SH; Park SY; Li JJ; Kwak SJ; Jung DS; Choi HY; Lee JE; Moon SJ; Kim DK; Han DS; Kang SW
Nephrol Dial Transplant; 2008 Jan; 23(1):169-75. PubMed ID: 17890747
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
Cade R; Mars D; Privette M; Thompson R; Croker B; Peterson J; Campbell K
Arch Intern Med; 1986 Apr; 146(4):737-41. PubMed ID: 3963956
[TBL] [Abstract][Full Text] [Related]
10. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
Sabry A; El-Husseini A; El-Dahshan K; Sobh M
Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
12. Natural history and response to treatment of minimal change nephrotic syndrome.
Prabhakar KS; Prakash KC; Mani MK
J Assoc Physicians India; 1993 May; 41(5):263-5. PubMed ID: 8300454
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[TBL] [Abstract][Full Text] [Related]
15. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
Fukudome K; Fujimoto S; Sato Y; Kitamura K
Nephrology (Carlton); 2012 Mar; 17(3):263-8. PubMed ID: 22117558
[TBL] [Abstract][Full Text] [Related]
17. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
18. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
[TBL] [Abstract][Full Text] [Related]
19. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
20. The role of pure diffuse mesangial hypercellularity in patients with proteinuria.
Griveas I; Stavianoudakis G; Karanikas E; Gogos K; Nakopoulou L
Ren Fail; 2009; 31(3):192-5. PubMed ID: 19288323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
